» Articles » PMID: 35348851

Ganoderma Immunomodulatory Proteins: Mushrooming Functional FIPs

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Fungal immunomodulatory protein (FIP) is a novel functional protein family with specific immunomodulatory activity identified from several macro-fungi. A variety of biological activities of FIPs have been reported, such as anti-allergy, anti-tumor, mitogenic activity, and immunomodulation. Among all known FIPs, the firstly discovered FIP was isolated from Ganoderma lucidum, and most FIP members were from Ganoderma genus. Compared with other FIPs, Ganoderma FIPs possess some advantageous bioactivities, like stronger anti-tumor activity. Therein, gene sequences, protein structural features, biofunctions, and recombinant expression of Ganoderma FIPs were summarized and addressed, focusing on elucidating their anti-tumor activity and molecular mechanisms. Combined with current advances, development potential and application of Ganoderma FIPs were also prospected. KEY POINTS: • More than a dozen of reported FIPs are identified from Ganoderma species. • Ganoderma immunomodulatory proteins have superior anti-tumor activity with promising prospects and application. • Current review comprehensively addresses characterization, biofunctions, and anti-tumor mechanisms of Ganoderma FIPs.

Citing Articles

Identification a novel Ganoderma FIP gene from Ganoderma capense and its functional expression in Pichia pastoris.

Lin J, Liao Y, Yang S, Jin T, Yu B, Zhao K World J Microbiol Biotechnol. 2024; 40(2):69.

PMID: 38225505 DOI: 10.1007/s11274-023-03869-w.


In Silico functional and phylogenetic analyses of fungal immunomodulatory proteins of some edible mushrooms.

Ramlal A, Samanta A AMB Express. 2022; 12(1):159.

PMID: 36571664 PMC: 9791630. DOI: 10.1186/s13568-022-01503-w.


Safety assessment of the fungal immunomodulatory protein from (GMI) derived from engineered : Genetic toxicology, a 13-week oral gavage toxicity study, and an embryo-fetal developmental toxicity study in Sprague-Dawley rats.

Fu H, Hseu R Toxicol Rep. 2022; 9:1240-1254.

PMID: 36518484 PMC: 9742912. DOI: 10.1016/j.toxrep.2022.05.013.

References
1.
Bastiaan-Net S, Chanput W, Hertz A, Zwittink R, Mes J, Wichers H . Biochemical and functional characterization of recombinant fungal immunomodulatory proteins (rFIPs). Int Immunopharmacol. 2012; 15(1):167-75. DOI: 10.1016/j.intimp.2012.11.003. View

2.
Brenner E, Schorg B, Ahmetlic F, Wieder T, Hilke F, Simon N . Cancer immune control needs senescence induction by interferon-dependent cell cycle regulator pathways in tumours. Nat Commun. 2020; 11(1):1335. PMC: 7067802. DOI: 10.1038/s41467-020-14987-6. View

3.
Chen Y, Shin J, Wei H, Lin C, Yu L, Liao W . Prevention of dextran sulfate sodium-induced mouse colitis by the fungal protein Ling Zhi-8 promoting the barrier function of intestinal epithelial cells. Food Funct. 2021; 12(4):1639-1650. DOI: 10.1039/d0fo02604b. View

4.
Cheng Z, Garvin D, Paguio A, Moravec R, Engel L, Fan F . Development of a robust reporter-based ADCC assay with frozen, thaw-and-use cells to measure Fc effector function of therapeutic antibodies. J Immunol Methods. 2014; 414:69-81. DOI: 10.1016/j.jim.2014.07.010. View

5.
Chu C, Chen D, Lin C . A novel adjuvant Ling Zhi-8 for cancer DNA vaccines. Hum Vaccin. 2011; 7(11):1161-4. DOI: 10.4161/hv.7.11.17753. View